Skip to content

Oruka Therapeutics

US · ORKA #2003 by market cap Listed 1970
95.81 -1.76 -1.80%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 11 analysts

Buy
Avg price target 148.44 +54.9%
Price target rangecurrent 95.81
Low105.00
Avg148.44
High180.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 UBS -- Buy 130.00
2026-11-10 Piper Sandler -- Buy 180.00
2026-11-10 Stifel -- Buy 150.00
2026-11-10 H.C. Wainwright -- Buy 120.00
2026-11-10 Barclays -- Buy 160.00
2026-11-09 BTIG -- Buy 151.00
2026-10-27 Wedbush -- Buy 165.00
2026-10-27 Leerink Partners -- Buy --
2026-10-27 H.C. Wainwright -- Buy 120.00
2026-10-27 Barclays -- Buy 160.00
2026-10-26 BTIG -- Buy 151.00
2026-10-26 Clear Street -- Buy 105.00
2026-10-18 BTIG -- Buy 151.00
2026-10-07 Piper Sandler -- Buy 180.00
2026-10-01 BTIG -- Buy 151.00
2026-09-24 Wedbush -- Buy 165.00
2026-09-24 H.C. Wainwright -- Buy 120.00
2026-09-23 LifeSci Capital -- Buy 175.00
2026-09-23 Clear Street -- Buy 131.00
2026-09-21 Barclays -- Buy 160.00
2026-09-09 LifeSci Capital -- Buy 175.00
2026-09-03 H.C. Wainwright -- Buy 120.00
2026-09-01 UBS -- Buy 130.00
2026-08-26 TD Cowen -- Buy --
2026-08-17 Piper Sandler -- Buy 180.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.

Oruka Therapeutics discussion 0 comments

Add a comment